Brief: Nova Eye Medical Announces FY21 Trading Update
July 20 (Reuters) - Nova Eye Medical Ltd EYE.AX :
* FY21 TRADING UPDATE-EYE.AX
* FY21 UNAUDITED GROUP REVENUES OF A$13.2-A$13.5 MILLION
* FY21 UNAUDITED GROUP EBITDA LOSS OF A$3.4-A$3.7 MILLION
Source text for Eikon: ID:nASX3sp0Wp
Further company coverage: EYE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment